As described above, comparison with zolpidem and triazolam shows that zaleplon has both a more rapid onset of effect and a shorter elimination half-life, [27] properties that allow for more ...

Zaleplon (Zalpilo (10 mg)) is a sedative/hypnotic, prescribed for insomnia. The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to ...

Learn everything you need to know about Zaleplon-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

PITTSBURGH The Food and Drug Administration has granted final approval for Mylan subsidiary Genpharm’s application for 5mg and 10mg Zaleplon Capsules, Mylan announced Monday. Zaleplon Capsules are a ...

Sleepwalking, sleep-driving, and sleep-using-a-stove are not things that you want to do. Therefore, the U.S. Food and Drug Administration on Tuesday announced that eszopiclone, zaleplon, and zolpidem ...

JERUSALEM, ISRAEL--(Marketwired - Dec 16, 2015) - Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary ...

The Assessment Report reviewed data from 24 randomised controlled trials (RCTs) that compared the Z-drugs with either a benzodiazepine or with another Z-drug in patients with insomnia. In total, 11 ...

Mumbai: Pharmaceutical firm Aurobindo Pharma said it has received US regulatory approval to market Zaleplon capsules, used in the treatment of insomnia. “The company has received final approval from ...

Certain commonly used sleeping pills will now contain a new boxed warning alerting patients to possible serious or life-threatening behaviors that may result from taking these drugs, the US Food and ...

Insomnia is a highly prevalent sleep problem that affects multiple aspects of daily life. Zaleplon, a novel nonbenzodiazepine sleep medication, represents a therapeutic advance by virtue of its ...

The Department of Health and the National Assembly for Wales have asked the National Institute for Clinical Excellence (NICE or the Institute) to conduct an appraisal of zaleplon, zolpidem and ...